Jeremy Grantham Ionis Pharmaceuticals Inc Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $29.8 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$474 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$384 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$345 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$263 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.75B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...